These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19917705)

  • 1. TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection.
    Faust SM; Lu G; Wood SC; Bishop DK
    J Immunol; 2009 Dec; 183(11):7307-13. PubMed ID: 19917705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection.
    Faust SM; Lu G; Marini BL; Zou W; Gordon D; Iwakura Y; Laouar Y; Bishop DK
    J Immunol; 2009 Dec; 183(11):7297-306. PubMed ID: 19917689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.
    Booth AJ; Csencsits-Smith K; Wood SC; Lu G; Lipson KE; Bishop DK
    Am J Transplant; 2010 Feb; 10(2):220-30. PubMed ID: 19788504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cardiac allograft survival across an MHC mismatch after "pruning" of alloreactive CD4 T cells.
    Hu M; Watson D; Zhang GY; Graf N; Wang YM; Sartor M; Howden B; Fletcher J; Alexander SI
    J Immunol; 2008 May; 180(10):6593-603. PubMed ID: 18453578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
    Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM
    Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model.
    Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI
    Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
    Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
    J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis.
    Booth AJ; Wood SC; Cornett AM; Dreffs AA; Lu G; Muro AF; White ES; Bishop DK
    J Pathol; 2012 Mar; 226(4):609-18. PubMed ID: 21960174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection.
    Diaz JA; Booth AJ; Lu G; Wood SC; Pinsky DJ; Bishop DK
    Am J Transplant; 2009 Aug; 9(8):1773-83. PubMed ID: 19538487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High transforming growth factor-beta and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection.
    Eikmans M; Sijpkens YW; Baelde HJ; de Heer E; Paul LC; Bruijn JA
    Transplantation; 2002 Feb; 73(4):573-9. PubMed ID: 11889433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.
    Morita K; Miura M; Paolone DR; Engeman TM; Kapoor A; Remick DG; Fairchild RL
    J Immunol; 2001 Sep; 167(5):2979-84. PubMed ID: 11509648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival.
    Li J; Meinhardt A; Roehrich ME; Golshayan D; Dudler J; Pagnotta M; Trucco M; Vassalli G
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3415-23. PubMed ID: 17933973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens.
    Shirasugi N; Adams AB; Durham MM; Lukacher AE; Xu H; Rees P; Cowan SR; Williams MA; Pearson TC; Larsen CP
    J Immunol; 2002 Sep; 169(5):2677-84. PubMed ID: 12193741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta-induced connective tissue growth factor and chronic allograft rejection.
    Csencsits K; Wood SC; Lu G; Faust SM; Brigstock D; Eichwald EJ; Orosz CG; Bishop DK
    Am J Transplant; 2006 May; 6(5 Pt 1):959-66. PubMed ID: 16611331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance.
    Xie L; Ichimaru N; Morita M; Chen J; Zhu P; Wang J; Urbanellis P; Shalev I; Nagao S; Sugioka A; Zhong L; Nonomura N; Takahara S; Levy GA; Li XK
    Liver Transpl; 2012 Apr; 18(4):444-54. PubMed ID: 22162188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
    Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
    Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.